Global Antidotes Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ888220 No. of Pages: 133 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Antidotes market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.
This report studies the Antidotes market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Antidotes in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Chemical Antidotes
Physical Antidotes
Pharmacological Antidotes
Market Snapshot, By Application
Pesticide Poisoning
Heavy Metal Poisoning
Animal Bites Poisoning
Cyanide Poisoning
Others
Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia
Main Market Players Analyzed in this report, including:
Roche
Pfizer
Teva
Bayer
Boehringer Ingelheim
Baxter
Novartis
Eli Lilly
Johnson & Johnson
Furen Pharmaceutical
Fresenius Kabi
Mylan
The study objectives of this report are:
To study and analyze the global Antidotes market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Antidotes market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Antidotes manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antidotes market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Antidotes submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antidotes are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Antidotes Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Antidotes Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Antidotes
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Antidotes Sales Channel and Distributors Analysis
3.3.1 Antidotes Sales Channel
3.3.2 Antidotes Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Antidotes Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Antidotes Type Introduction
4.1.1 Chemical Antidotes
4.1.2 Physical Antidotes
4.1.3 Pharmacological Antidotes
4.2 Global Antidotes Sales by Type 2016-2021
4.3 Global Antidotes Revenue by Type 2016-2021
4.4 Global Antidotes Price by Type 2016-2021
5 Market Segment: by Application
5.1 Antidotes Type Introduction
5.1.1 Pesticide Poisoning
5.1.2 Heavy Metal Poisoning
5.1.3 Animal Bites Poisoning
5.1.3 Cyanide Poisoning
5.1.4 Others
5.2 Global Antidotes Sales by Application 2016-2021
5.3 Global Antidotes Revenue by Application 2016-2021
5.4 Global Antidotes Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Antidotes Market by Region
6.1.1 Global Antidotes Sales by Regions
6.1.2 Global Antidotes Revenue by Regions
6.2 North America Antidotes Market 2016-2021
6.3 Europe Antidotes Market 2016-2021
6.4 Asia Pacific Antidotes Market 2016-2021
6.5 South America Antidotes Market 2016-2021
6.6 Middle East and Africa Antidotes Market 2016-2021
7 North America
7.1 North America Antidotes Market by Country 2016-2021
7.1.1 North America Antidotes Sales by Country
7.1.2 North America Antidotes Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Antidotes Market by Country 2016-2021
8.1.1 Europe Antidotes Sales by Country
8.1.2 Europe Antidotes Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Antidotes Market by Country 2016-2021
9.1.1 Asia Pacific Antidotes Sales by Country
9.1.2 Asia Pacific Antidotes Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Antidotes Market by Country 2016-2021
10.1.1 South America Antidotes Sales by Country
10.1.2 South America Antidotes Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Antidotes Market by Country 2016-2021
11.1.1 Middle East and Africa Antidotes Sales by Country
11.1.2 Middle East and Africa Antidotes Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Roche
12.1.1 Roche Company Information
12.1.2 Roche Antidotes Product Portfolio, Specification and Application
12.1.3 Roche Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Roche Key Development
12.2 Pfizer
12.2.1 Pfizer Company Information
12.2.2 Pfizer Antidotes Product Portfolio, Specification and Application
12.2.3 Pfizer Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Pfizer Key Development
12.3 Teva
12.3.1 Teva Company Information
12.3.2 Teva Antidotes Product Portfolio, Specification and Application
12.3.3 Teva Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Teva Key Development
12.4 Bayer
12.4.1 Bayer Company Information
12.4.2 Bayer Antidotes Product Portfolio, Specification and Application
12.4.3 Bayer Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Bayer Key Development
12.5 Boehringer Ingelheim
12.5.1 Boehringer Ingelheim Company Information
12.5.2 Boehringer Ingelheim Antidotes Product Portfolio, Specification and Application
12.5.3 Boehringer Ingelheim Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Boehringer Ingelheim Key Development
12.6 Baxter
12.6.1 Baxter Company Information
12.6.2 Baxter Antidotes Product Portfolio, Specification and Application
12.6.3 Baxter Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Baxter Key Development
12.7 Novartis
12.7.1 Novartis Company Information
12.7.2 Novartis Antidotes Product Portfolio, Specification and Application
12.7.3 Novartis Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Baxter Key Development
12.9 Johnson & Johnson
12.9.1 Johnson & Johnson Company Information
12.9.2 Johnson & Johnson Antidotes Product Portfolio, Specification and Application
12.9.3 Johnson & Johnson Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Johnson & Johnson Key Development
12.8 Eli Lilly
12.8.1 Eli Lilly Company Information
12.8.2 Eli Lilly Antidotes Product Portfolio, Specification and Application
12.8.3 Eli Lilly Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Eli Lilly Key Development
12.11 Fresenius Kabi
12.11.1 Fresenius Kabi Company Information
12.11.2 Fresenius Kabi Antidotes Product Portfolio, Specification and Application
12.11.3 Fresenius Kabi Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Fresenius Kabi Key Development
12.12 Mylan
12.12.1 Mylan Company Information
12.12.2 Mylan Antidotes Product Portfolio, Specification and Application
12.12.3 Mylan Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Mylan Key Development
13 Global Antidotes Market Forecast by Region by Type and by Application
13.1 Global Antidotes Sales, Revenue Forecast 2022-2027
13.2 Global Antidotes Forecast by Regions
13.2.1 Global Antidotes Sales Forecast by Region 2022-2027
13.2.2 Global Antidotes Revenue Forecast by Region 2022-2027
13.3 Global Antidotes Forecast by Type
13.3.1 Global Antidotes Sales Forecast by Type 2022-2027
13.3.2 Global Antidotes Revenue Forecast by Type 2022-2027
13.3.3 Global Antidotes Price Forecast by Type 2022-2027
13.4 Global Antidotes Forecast by Application
13.4.1 Global Antidotes Sales Forecast by Application 2022-2027
13.4.2 Global Antidotes Revenue Forecast by Application 2022-2027
13.4.3 Global Antidotes Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
List of Tables
Table 1: Global Antidotes Production Specifications
Table 2: Drivers in Antidotes Market
Table 3: Restraints Antidotes Market
Table 4: Opportunity in Antidotes Market
Table 5: Comparion of Alternative and Antidotes
Table 6: Antidotes Raw Materials Key Suppliers List
Table 7: Antidotes Distributors List
Table 8: Antidotes Major Buyers in Application One
Table 9: Antidotes Major Buyers in Application Two
Table 10: Antidotes Major Buyers in Application Three
Table 11: Global Antidotes Sales (K Units) by Type 2016-2021
Table 12: Global Antidotes Sales Market Share by Type 2016-2021
Table 13: Global Antidotes Revenue (Million USD) by Type 2016-2021
Table 14: Global Antidotes Revenue Market Share by Type 2016-2021
Table 15: Global Antidotes Price by Type 2016-2021
Table 16: Global Antidotes Sales (K Units) by Application 2016-2021
Table 17: Global Antidotes Sales Market Share by Application 2016-2021
Table 18: Global Antidotes Revenue (Million USD) by Application 2016-2021
Table 19: Global Antidotes Revenue Market Share by Application 2016-2021
Table 20: Global Antidotes Price by Application 2016-2021
Table 21: Global Antidotes Sales (K Units) by Region 2016-2021
Table 22: Global Antidotes Sales Market Share by Region 2016-2021
Table 23: Global Antidotes Revenue (Million USD) by Region 2016-2021
Table 24: Global Antidotes Revenue Market Share by Region 2016-2021
Table 25: North America Antidotes Sales (K Units) by Country 2016-2021
Table 26: North America Antidotes Sales Market Share by Country 2016-2021
Table 27: North America Antidotes Revenue (Million USD) by Country 2016-2021
Table 28: North America Antidotes Revenue Market Share by Country 2016-2021)
Table 29: Europe Antidotes Sales (K Units) by Country 2016-2021
Table 30: Europe Antidotes Sales Market Share by Country 2016-2021
Table 31: Europe Antidotes Revenue (Million USD) by Country 2016-2021
Table 32: Europe Antidotes Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Antidotes Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Antidotes Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Antidotes Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Antidotes Revenue Market Share by Country 2016-2021)
Table 37: South America Antidotes Sales (K Units) by Country 2016-2021
Table 38: South America Antidotes Sales Market Share by Country 2016-2021
Table 39: South America Antidotes Revenue (Million USD) by Country 2016-2021
Table 40: South America Antidotes Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Antidotes Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Antidotes Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Antidotes Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Antidotes Revenue Market Share by Country 2016-2021)
Table 45 Roche Company Information
Table 46 Roche Antidotes Product Portfolio, Specification and Application
Table 47 Roche Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Pfizer Company Information
Table 49 Pfizer Antidotes Product Portfolio, Specification and Application
Table 50 Pfizer Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Teva Company Information
Table 52 Teva Antidotes Product Portfolio, Specification and Application
Table 53 Teva Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Bayer Company Information
Table 55 Bayer Antidotes Product Portfolio, Specification and Application
Table 56 Bayer Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Boehringer Ingelheim Company Information
Table 58 Boehringer Ingelheim Antidotes Product Portfolio, Specification and Application
Table 59 Boehringer Ingelheim Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Baxter Company Information
Table 61 Baxter Antidotes Product Portfolio, Specification and Application
Table 62 Baxter Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Novartis Company Information
Table 64 Novartis Antidotes Product Portfolio, Specification and Application
Table 65 Novartis Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Eli Lilly Company Information
Table 67 Eli Lilly Antidotes Product Portfolio, Specification and Application
Table 68 Eli Lilly Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Johnson & Johnson Company Information
Table 70 Johnson & Johnson Antidotes Product Portfolio, Specification and Application
Table 71 Johnson & Johnson Antidotes Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Antidotes Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Antidotes Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Antidotes Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Antidotes Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Antidotes Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Antidotes Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Antidotes Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Antidotes Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Antidotes Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Antidotes Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Antidotes Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Antidotes Revenue Market Share Forecast by Application (2022-2027)
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com